-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $41

Benzinga·09/17/2026 13:12:18
Listen to the news
Lake Street analyst Daniel Brims initiates coverage on Kyntra Bio (NASDAQ:KYNB) with a Buy rating and announces Price Target of $41.